Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
Earnings for Biocon Limited (BIOCON.NS)
Earnings in 2023 (TTM): $191.63 M
According to Biocon Limited's latest financial reports the company's current earnings (TTM) are $191.63 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Biocon Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $191.63 M | $121.75 M |
| 2022 | $106.82 M | $55.09 M |
| 2021 | $117.06 M | $77.21 M |
| 2020 | $128.29 M | $88.17 M |
| 2019 | $141.22 M | $89.09 M |
| 2018 | $144.66 M | $107.8 M |
| 2017 | $72.63 M | $44.34 M |
| 2016 | $101.18 M | $72.88 M |
| 2015 | $146.15 M | $106.7 M |
| 2014 | $74.31 M | $59.23 M |
| 2013 | $64.02 M | $49.27 M |
| 2012 | $72.66 M | $60.6 M |
| 2011 | $46.74 M | $40.29 M |
| 2010 | $53.25 M | $43.76 M |
| 2009 | $41.85 M | $34.92 M |
| 2008 | $30.96 M | $11.09 M |
| 2007 | $27.49 M | $55.24 M |
| 2006 | $25.12 M | $23.85 M |
| 2005 | $24.12 M | $20.71 M |
| 2004 | $25.61 M | $23.52 M |
| 2003 | $19.25 M | $16.51 M |